HASOMED HARD-UND SOFTWARE FUER MEDIZIN GESELLSCHAFT MBH

Their core work

HASOMED GmbH (Hardware and Software for Medicine) is a Magdeburg-based medical technology SME that develops software and hardware systems for clinical rehabilitation and neurological therapy. Their core business centers on computer-assisted rehabilitation tools used in hospitals and therapy centers, with particular depth in motor and cognitive recovery applications. In H2020, they contributed their clinical software expertise to consortia working on robotic rehabilitation for neurological patients and diagnostic tools for age-related conditions. They are the kind of partner that bridges research prototypes and real clinical deployment — a technology-to-product translator in the medical devices space.

What they specialise in

How they've shifted over time

HASOMED's two projects overlap substantially in timeline (2015-2019 and 2017-2021), making a clean early-vs-late split difficult to draw. What is visible is a move from an applied innovation project (RETRAINER, an Innovation Action) toward a longer-horizon academic training network (Keep Control, MSCA-ITN), suggesting growing interest in building research relationships alongside product-focused work. No keyword data is available for either period, so this reading is cautious and based solely on funding scheme and sector labels.

HASOMED appears to be broadening from device-focused rehabilitation projects toward longer-term research networks in neurodegeneration, which could position them for health-tech consortia targeting Parkinson's, dementia, or stroke recovery over the next funding cycle.

How they like to work

HASOMED has participated exclusively as a partner — never as coordinator — across both H2020 projects, which is typical for specialist SMEs that contribute a validated product or platform rather than leading the research agenda. Their 20 unique partners across 9 countries from just two projects indicates engagement in large, multi-actor consortia rather than tight bilateral arrangements. This suggests they are comfortable operating in complex international settings and know how to position their technology within broader research programmes.

HASOMED has built connections with 20 distinct organisations across 9 European countries through only two projects, suggesting their consortia are broad and geographically diverse. Their Magdeburg base places them in eastern Germany's emerging health-tech corridor, but their collaboration footprint extends well beyond that region.

What sets them apart

HASOMED occupies a specific niche that few SMEs fill well: they are a practicing medical software and hardware company that can integrate research outputs into real clinical workflows. Unlike university spinoffs or pure-play research groups, they bring regulatory awareness, existing hospital customer relationships, and a product-development mindset to consortia. For any project that needs to move from prototype to clinical pilot, a partner like HASOMED can accelerate that bridge significantly.

Highlights from their portfolio

• RETRAINER
  HASOMED's largest H2020 award (EUR 330,488) and an Innovation Action — the funding scheme closest to market deployment — making it the clearest signal of their applied, product-oriented rehabilitation technology capabilities.
• Keep Control
  Participation in an MSCA Initial Training Network shows HASOMED's willingness to engage with early-stage academic research and talent development, extending their reach beyond pure product work into the neuroscience training pipeline.